Company intelligence / Profile preview

BIOZOL Diagnostica

Eching, Bavaria, Germanybiozol.de ↗

Ownership: Private
Development stage: Other

Overview

BIOZOL offers a broad portfolio of over 350,000 products for research and routine diagnostics in immunology, cell biology, molecular biology and biochemistry. Their diagnostic products are compliant with international standards (including CE marking), suitable for use as in vitro diagnostic medical devices in humans and animals. The company provides both distribution of third-party brands and its own branded products. They also offer custom analytical testing services using ELISAs and other assay platforms.

Therapeutic areas: Metabolic DisordersEndocrinologyOncologyImmunologyCardiovascular
Modalities: AntibodyELISA kitReagentSmall moleculeBiologic
Industry: Protein Biomarker Diagnostics

Partnerships

Represents almost 40 worldwide suppliers in GermanyPartners include Creative Diagnostics

Beyond the preview

Go deeper on BIOZOL Diagnostica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOZOL Diagnostica.

Explore the full profile